PathPresenter
PrivateLast Round
Series A
Sep 12, 2024
Total Funding Raised
$7.5M
Company Overview
PathPresenter is a healthcare technology company that provides an enterprise-grade image management and workflow platform for digital pathology, enabling clinical care, remote consultations, research, and education.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathPresenter Comparables
Compare PathPresenter with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gestalt Diagnostics | 87% | |
| Proscia | 87% | |
| Corista | 87% |
PathPresenter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 12, 2024 |
Key People
Founding team and executive leadership
PathPresenter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Modi Ventures | Series A |
| AVANT BIO | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Grew 21% QoQ, from 38 to 46 employees.
- Oct 3, 2025
Remote second opinion web portal now generally available on AWS.
PathPresenter Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PathPresenter's valuation, stock price, and market status.
Is PathPresenter a public or private company?
PathPresenter is a private company.
What is the current stock price of PathPresenter?
PathPresenter is a private company with no public stock price. No recent secondary market data is available.
How much is PathPresenter worth (valuation)?
Valuation information for PathPresenter is not publicly available.
Can I buy PathPresenter stock?
PathPresenter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PathPresenter's last funding round?
PathPresenter's most recent funding round was Series A on September 12, 2024.
Who are the main investors in PathPresenter?
Key investors in PathPresenter include AVANT BIO.
Will PathPresenter IPO soon?
No public IPO plans have been announced for PathPresenter.
How can I track PathPresenter secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PathPresenter's secondary market activity and sign up for updates.